General Information
Revision date
2019-01-08
Product name
Doxorubicin hydrochloride
CAS No.
25316-40-9
1.2.1 Relevant identified uses
Reference material for laboratory use only
1.2.2. Uses advised against
No further relevant information available
Emergency telephone
department
Icons in SDS
Company Information
company name
LGC Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gb@lgcstandards.com, sds-request@lgcgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H341, H351
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
GHS08 health hazard Muta. 2 H341 Suspected of causing genetic defects. Carc. 2 H351 Suspected of causing cancer. GHS07 Acute Tox. 4 H302 Harmful if swallowed.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 The substance is classified and labelled according to the CLP regulation. (Contd. from page 1)
Hazard pictograms
GHS07 GHS08
Hazard statements
H302 Harmful if swallowed. H341 Suspected of causing genetic defects. H351 Suspected of causing cancer.
Precautionary statements
P264 Wash thoroughly after handling. P280 Wear protective gloves/protective clothing/eye protection/face protection. P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. P308+P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
PBT Substances
Not applicable
vPvB Substances
Not applicable
